Compare ACOG & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACOG | STHO |
|---|---|---|
| Founded | 2000 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.5M | 112.7M |
| IPO Year | N/A | N/A |
| Metric | ACOG | STHO |
|---|---|---|
| Price | $6.60 | $8.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 106.2K | 58.8K |
| Earning Date | 11-13-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,427,199.00 | ★ $117,547,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $132.35 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.75 | $6.06 |
| 52 Week High | $11.54 | $9.87 |
| Indicator | ACOG | STHO |
|---|---|---|
| Relative Strength Index (RSI) | 58.86 | 64.78 |
| Support Level | $5.61 | $7.33 |
| Resistance Level | $6.91 | $8.33 |
| Average True Range (ATR) | 0.55 | 0.25 |
| MACD | 0.14 | 0.07 |
| Stochastic Oscillator | 80.04 | 90.82 |
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.